TrialClinical and experimental immunology2009

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

S L Thrower et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.